| Minnesota Criminal Justice Statute Service | Bureau of Criminal Apprehension

151.34(15)

Statute ID: 15355

Statute Function ID: 32953

Pharmacy - Sell Compound, Substance or Derivative not FDA approved; Effect Similar to Schd I or II

In Effect

New Search Refine Search Back to Results

Charge

Classifications

Offense Level:

Misdemeanor (M)

General Offense Code:

Drug (3)

Offense Summary Code & Rank:

Drugs (D) (Rank 14)

Detailed Offense Code:

Drug Offense (399)

Offense Severity Level:

Function Text:

UCR Code

Description

90Z

All Other Offenses

Flags

Crime of Violence:

Targeted Misdemeanor:

Predatory Offender Registration Review:

Enhanceable:

Certify to DPS:

Report to DNR:

DPS Group:

Conditional Release:

Payable:

Petty Misdemeanor Only if Prosecutor Certifies:

Third Violation Indicator:

Qualified Domestic Violence Related:

Nonviolent Controlled Substance Offender Review:

Wildlife Restitution:

Statute Number:

151.34(15)

Enactment Date:

May 21, 2014

Effective Date:

Aug 1, 2014

Expiration Date:

Repealed?:

Summary Text:

Pharmacy - Sell Compound, Substance or Derivative not FDA approved; Effect Similar to Schd I or II

Statute ID:

15355

Created:

Jul 15, 2014 by mnjis.legal.analyst@state.mn.us

Updated:

Jul 15, 2014 by mnjis.legal.analyst@state.mn.us

Last Update Action:

Added

Legal Analyst Comment:

Amended 2014 c 285 s 5; Amendments to (7), (9) and new (15); Misdemeanor; Petty if Certified

Summary Text:

Pharmacy - Sell Compound, Substance or Derivative not FDA approved; Effect Similar to Schd I or II

Link to MN Statute Text:

https://www.revisor.leg.state.mn.us/stats/151/34.html

Legislative Session:

2014 - Regular

Session Law Text?:

Statute text last updated on:

Jul 10, 2019

It shall be unlawful to:
(1) manufacture, sell or deliver, hold or offer for sale any drug that is adulterated or misbranded;
(2) adulterate or misbrand any drug;
(3) receive in commerce any drug that is adulterated or misbranded, and to deliver or proffer delivery thereof for pay or otherwise;
(4) refuse to permit entry or inspection, or to permit the taking of a sample, or to permit access to or copying of any record as authorized by this chapter;
(5) remove or dispose of a detained or embargoed article in violation of this chapter;
(6) alter, mutilate, destroy, obliterate, or remove the whole or any part of the labeling of, or to do any other act with respect to a drug, if such act is done while such drug is held for sale and results in such drug being adulterated or misbranded;
(7) use for a person's own advantage or to reveal other than to the board or its authorized representative or to the courts when required in any judicial proceeding under this chapter any information acquired under authority of this chapter concerning any method or process that is a trade secret and entitled to protection;
(8) use on the labeling of any drug any representation or suggestion that an application with respect to such drug is effective under the federal act or that such drug complies with such provisions;
(9) in the case of a manufacturer, packer, or distributor offering legend drugs for sale within this state, fail to maintain for transmittal or to transmit, to any practitioner licensed by applicable law to administer such drug who makes written request for information as to such drug, true and correct copies of all printed matter that is required to be included in any package in which that drug is distributed or sold, or such other printed matter as is approved under the federal act. Nothing in this paragraph shall be construed to exempt any person from any labeling requirement imposed by or under provisions of this chapter;
(10) conduct a pharmacy without a pharmacist in charge;
(11) dispense a legend drug without first obtaining a valid prescription for that drug;
(12) conduct a pharmacy without proper registration with the board;
(13) practice pharmacy without being licensed to do so by the board;
(14) sell at retail federally restricted medical gases without proper registration with the board except as provided in this chapter; or
(15) sell any compound, substance, or derivative that is not approved for human consumption by the United States Food and Drug Administration or specifically permitted for human consumption under Minnesota law, and, when introduced into the body, induces an effect similar to that of a Schedule I or Schedule II controlled substance listed in section 152.02, subdivisions 2 and 3, or Minnesota Rules, parts 6800.4210 and 6800.4220, regardless of whether the substance is marketed for the purpose of human consumption.